Stifel Nicolaus analyst Simon Yarmak maintained a Buy rating on Realty Income (O – Research Report) today and set a price target of $66.50. The ...

Stifel lowered the firm’s price target on Inspire Medical (INSP) to $190 from $200 and keeps a Hold rating on the shares. The firm notes in early January, Inspire’s stock floated higher ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

With inflation continuing to improve, the downward path of central bank rates remains on track, if uneven geographically ...

Welcome to the Q4 2024 Intuitive earnings conference call. At this time, all participants are in a listen-only mode. Please ...

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Copyright © 2025 MarketWatch, Inc. All rights reserved.

How the savvy bond investor can beat Wall Street at its own game Investopedia contributors come from a range of backgrounds, and over 25 years there have been thousands of expert writers and ...